Introduction: Etiology of thrombosis in malignant diseases is multifactorial, and mechanisms that lead to thrombosis include release of the procoagulants from tumor cells (PC), factor related to bed rest, infections, as well as oncological therapy -chemotherapy, hormones, radiotherapy and surgical treatment. Thrombocytosis has freq-uently been found to be associated with various malignancies. Case report: 53 years old female patient hospitalised because of hypopharingeal cancer with metastasis in the left neck. Her state was complicated with deep leg vein trombosis and pseudomonas infection. Persistent thrombocitosis in laboratory monitoring indicated more adequate diagnostic procedures, which led to discovering of Chorioidal Malignant Mellanoma as a second cancer. She was treated: surgicaly, with antibiotics, with anticoagulants and radiotherapy. Patient was discharged from the hospital in good health condition, free of any other symptom of the malignant disease. Conclusion: Presense of thrombocytosis and idiopatic thrombosis can suggest occult malignancy. It would be prudent to further evaluate the relationship of trombotic events, trombocitosis and head and neck tumors. We suggest anticoagulants to prevent thromboembolic complications, affect the angiogenesis and prevent development of metastatic disease. It may lead to lower mortality rate.
L iability to thrombosis and embolism represents an important problem associated with cancer, although there are no evident haemostatic disorders. Malignant cells may activate the coagulation system: either directly -influencing thrombin production or indirectly through stimulation of the mononuclear cells to synthesize and secrete different procoagulant substances. The patients necessitating surgical treatment of the cancer are particularly prone to thrombosis and embolism within carcinoma therapy which makes the postoperative risks significantly higher. Radiotherapy and chemotherapy also increase the risk to thrombosis in cancer patients. Drug therapeutic regimen in cancer cases of acute thrombosis includes the application of fractioned and unfractioned heparins and oral anticoagulant therapy (OAT). 1 
CASE REPORT
A female patient aged 53, farmer. She was hospitalized at the Institute of othorhynolarynology and maxillofacial surgery Clinical Centre of Serbia (Inst ORL MFS CCS) because of hypopharingeal tumor, for panendoscopic evaluation. Immidiately after admission femopopliteal thrombosis developed in her left leg, and therefore she was administered anticoagulant therapy with low molecular weight heparin (LMWH) -Dalteparin sodium subcutaneus injection (s.c.). After stabilization of her clinical status, panendoscopy was performed and tumor of the tongue base tissue was evidented. Histopathological result (HP) was the following: medium differentiated squamous cell carcinoma, histological grade II, nuclear grade II, and thus resection of the tongue basis and modified radical dissection of the left neck were performed. In postoperative period, clinical state deteriorated-infection of tracheotomy induced by pseudomonas, body temperature was increased, persistent thrombocytosis, granulocytopenia-leukocitopenia, somatic examination also showed red flash and pain in the left lower leg. The patient was treated casually with Ceftazidime intravenous injestions and LMWH Dalteparin sodium sc.
Values of antitrombin III were within reference values (97%). In absense of tests for controling of the activated factor X (FXa), prothrombin time (PT) and activated partial tromboplastin time (aPTT) were used. Persisting the lasting thrombocytosis led the doctor's team to additional diagnostic procedures, that evidenced eye tumor. After seven days of treatment and covalescence period and switching to peroral feeding, oral anticoagulant therapy (OAT) Acenocumarol tablet was gradually introduced. Radiotherapy was not applied within the optimal time period due to the complications during postoperative period. Therefore, tumefaction developed on the left side of the neck, and the patient was surgically treated again. Radical dissection on the left side of the neck was performed. HP result indicated of metastasis of the squamous cell carcinoma in the soft tissue of the neck. Diagnosis was confirmed with immunohistochemistry: tumor cells are positive for cytokeratin and negative for HMB-45. Postoperative recovery was uneventful. Owing to the course of the underlying disease complicated by reccurent therombophlebitis, the patient was carefully laboratory monitored (INR, aPTT) and treated with Dalteparin natrium and OAT Warfarin sodium was gradually introduced. The patient was discharged without any clinical signs of acute phlebothrombosis. Tumor Board reached the decision to apply radiotherapy in postoperative period. At the end of clinical exploration enucleation was done and HP result was the following: Chorioidal Malignant Melanoma -transversial penetration. Complete clinical and diagnostic evaluation confirmed that the patient was free of any other symptoms of the disease involving other tissues and organs, in addition to those already mentioned . Now, eight months after all the applied therapeutical modalities patient's clinical condition is good. (graph 1)
DISCUSSION
This case proves that etiology of thrombosis in malignant diseases is multifactorial, and mechanisms that lead to thrombosis include release of the procoagulants from tumor cells (PC), factor related to bed rest, infections, as well as oncological therapy -chemotherapy, hormones, radiotherapy 2 . There are several mechanisms which can activate coagulation in case of infection: endotoxin directly activates factor XII, induces reaction of releasing in thrombocytes, causes damage of endothelium and starts releasing of procoagulant materials from granulocytes 3 . Development of thrombosis during second hospitalization, in spite of the treatment, along with development of thrombocytosis, indicated more adequate diagnostic procedures, which led to discovering of Chorioidal Malignant Mellanoma 4, 5 . Hypercoagulability states (thrombophilia) and thrombosis can appear several months, even years before tumor diagnosis 6 . Patients with cancer have twice as high risk for deep leg venous thrombosis than the patients without malignancy 7 . It is well known that malignancy incidence is highly related to coagulation disorders and apperance of thrombosis 8, 9 . Appearance of venous thromboembolism can be indicative of undetected occult carcinoma which increases the possibility of early detection, healing, prolonged survival 6, 10 . In solid tumors the vitamin-cancer-procoagulant, which is vitamin-K-dependant enzyme, may have a key role in antimetastatic effect of warfarin. Currently available studies suggest anticoagu-GRAPH 1 DAYS WHN OBSERVED PATIENTS WERE MEASURED lants as therapeutic and prophylactic agents in carcinoma patients, since they prevent thromboembolic complications, affect the angiogenesis and prevent development of metastatic disease, while the others suggest lower mortality among carcinoma patients treated with heparin and low molecular weight heparin 1 .
CONCLUSION
We have selected a patient with such a diverse clinical symptoms in order to remind our colleagues on the possibility of the clinical situations associated with treatment of patients multiple diseases that maybe cured only by team efforts. It must be stressed that the patient is highly motivated , willing to cooperate with medical team , with exceptionally stabile psychologically constitution. Our report is only a small contribution to more reliable clinical practice, when our mutual efforts result in patient's survival. So, don't forget:
In malignancy treatment, combined with all the above stated complications, causal approach is certainly the best one: extirpation of the whole tumor whenever possible, and treating of infection according to susceptibility test using the most efficient drug.
In patients with idiopathic thrombosis there is a possibility of occult malignancy, and thus it is necessary to direct diagnostic methods accordingly. Presence of peripheral blood thrombocytosis can also suggest presence of malignancy. Preoperative thrombocytosis suggest possible metastatic disease and implies choice of diagnostic procedures which will evidence metastatic changes with high level of accuracy.
Appearance of hypercoagulability in coagulation tests without clinical manifestations of illness presents: the marker for possible existence of malignancy, and, if there is the malignancy, marker of malignancy progression. Anticoagulant treatment prevents appearance of thromboembolic complications (infarction, cerebrovascular insult and embolism) and stops malignancy progression.
Within the preventive approach to thromboembolic states the drug of choice is warfarin, which maintains INR values within the range of 2,0-3,0 for cancer patients.
Within therapeutical approach to thromboembolic states drug of choice is LMWP.
The most contemporary treatment of malignancies includes multidisciplinary approach and translation of laboratory conclusions in clinical practice.
REZIME PACIJENT SA DVA KANCERA -USPE[NO LE^ENJE (prikaz slu~aja)
Uvod: Etiologija tromboze u malignim oboljenjima je multifaktorijalna. Mehanizmi koji vode do tromboze uklju~uju otpu{tanje prokoagulanata iz tumorskih }elija (PC), rizike koje nosi dugotrajno le'anje, infekcije, kao i onkolo{ka terapija-hemioterapija, hormoni, radioterapija i hirur{ko le~enje. Pojava trombocitoze je ~esto udru'ena sa raznim malignitetima.
Prikaz slu~aja: 53-godi{nja bolesnica hospitalizovana zbog kancera hipofarinksa sa metastazama na vratu levo.
Njeno stanje se komplikovalo dubokom venskom trombozom noge i infekcijom traheostome pseudomonasom. Tokom laboratorijskog monitoringa perzistentna trombocitoza je ukazivala na potrebu primene adekvatnih dijagnosti~kih procedura, koje su dovele do otkrivanja malignog melanoma horioidee, kao drugog karcinoma. Le~ena je: hiru{ki, antibioticima, antikoagulantnom terapijom i radioterapijom. Bolesnica je otpu{tena u dobrom op{tem stanju, bez znakova maligne bolesti.
Zaklju~ak: Prisustvo trombocitoze i idiopatske tromboze mogu ukazivati na okultni malignitet. Dalja istra'ivanja potrebno je usmeriti na evaluaciju povezanosti tromboza, trombocitoza i tumora regije glava-vrat. Autori preporu~uju antikoagulante za prevenciju tromboembolijskih komplikacija, ~ime bi se uticalo na angiogenezu i prevenciju razvoja metastatskog oboljenja. Ovo mo'e da rezultira smanjenjem stope mortaliteta kod pacijenta obolelih od malignih oboljenja.
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